CD86 and Cirrhosis: Activation marker expression on cDC2 in patients with cirrhosis and healthy donors did not differ significantly at baseline, but upon stimulation with CL097, cDC2 were less prone to upregulate expression of CD86 and HLA-DR (Supplementary Figure 2).